03:57:21 Europe / Stockholm

Svenska | English

Cessatech

Kalender

2023-03-17	Årsstämma 2023
2023-03-03	Bokslutskommuniké 2022
2022-11-18	Kvartalsrapport 2022-Q3
2022-11-04	Extra Bolagsstämma 2022
2022-08-19	Kvartalsrapport 2022-Q2
2022-04-19	Kvartalsrapport 2022-Q1
2022-03-18	Ordinarie utdelning CESSA 0.00 DKK
2022-03-17	Årsstämma 2022
2022-02-24	Bokslutskommuniké 2021
2021-11-19	Kvartalsrapport 2021-Q3
2021-08-19	Kvartalsrapport 2021-Q2
2021-04-19	Kvartalsrapport 2021-Q1
2021-03-29	Ordinarie utdelning CESSA 0.00 DKK
2021-03-26	Årsstämma 2021
2021-02-11	Bokslutskommuniké 2020

Beskrivning

Land	Danmark
Lista	Spotlight DK
Sektor	Hälsovård
Industri	Bioteknik

Cessatech är verksamma inom läkemedelsbranschen. Bolaget är specialiserade inom forskning och utveckling av smärtstillande nässpray som vidare används för behandling av akuta smärttillstånd hos barn. Utöver huvudverksamheten erbjuds även tillhörande kringtjänster och relaterade produkter. Verksamheten drivs globalt med störst närvaro inom den nordiska marknaden. Huvudkontoret ligger i Köpenhamn.

Filter

År

Typ

Språk

Rensa

2023-01-27 07:30:00 Cessatech: Welcome to 2023 and our January business update... 0,00% | 0,07 MDKK

2023-01-17 17:30:00 Cessatech: Grant of incentive warrants to Employees, CEO and the Board of Directors -4,90% | 0,09 MDKK

2022-12-07 16:00:00 Cessatech: CESSATECH'S COMPENSATION ISSUE IN CONNECTION WITH THE RECENT RIGHTS ISSUE HAS BEEN REGISTERED -0,52% | 0,02 MDKK

2022-11-24 17:00:00 Cessatech: CESSATECH'S BOARD RESOLVES ON COMPENSATION ISSUE IN CONNECTION WITH THE RECENT RIGHTS ISSUE -0,26% | 0,10 MDKK

2022-11-18 16:45:09 Cessatech: CESSATECH ANNOUNCES LAST DAY OF TRADING IN BTU AND THE FIRST DAY OF TRADING IN WARRANTS OF SERIES TO2 +4,37% | 0,04 MDKK

2022-11-18 08:30:00 Cessatech: Third quarter report Q3-2022 +4,37% | 0,04 MDKK

2022-11-14 14:06:21 Cessatech: CESSATECH ANNOUNCES OUTCOME OF RIGHTS ISSUE -5,36% | 0,12 MDKK

2022-11-08 11:18:59 Cessatech: TOMORROW IS THE LAST DAY OF THE SUBSCRIPTION PERIOD IN CESSATECH'S RIGHTS ISSUE +3,38% | 0,04 MDKK

2022-11-04 10:21:48 Cessatech: Minutes of the Extraordinary general meeting +7,02% | 0,10 MDKK

2022-10-27 17:30:00 Cessatech: THE SUBSCRIPTION PERIOD HAS STARTED IN CESSATECH'S RIGHTS ISSUE +9,32% | 0,02 MDKK

2022-10-20 18:00:00 Cessatech: Extraordinary general meeting -9,80% | 0,07 MDKK

2022-10-20 08:30:00 Cessatech: CESSATECH PUBLISHES OFFERING MEMORANDUM IN CONNECTION WITH 80% GUARANTEED RIGHTS ISSUE -46,54% | 0,48 MDKK

2022-10-19 18:00:00 Cessatech: CESSATECH ANNOUNCES DKK 18.3 MILLION CAPITAL RAISE THROUGH A 80% GUARANTEED RIGHTS ISSUE TO FINANCE PIVOTAL DEVELOPMENT OF CT001 -46,54% | 0,48 MDKK

2022-10-10 17:00:00 Cessatech: Great progress during Q3 - more to come -1,41% | 0,03 MDKK

2022-09-23 08:30:00 Cessatech reports successful outcome of pharmacokinetic trial in children of lead candidate -6,25% | 0,28 MDKK

2022-09-05 17:30:00 Cessatech reports first patient dosed in pivotal trial of lead product candidate +9,25% | 0,09 MDKK

2022-08-19 08:30:00 Cessatech: Second quarter report Q2-2022 - green light for the pivotal trial 0205 -4,37% | 0,09 MDKK

2022-08-11 08:30:00 Cessatech: Good things are worth waiting for - welcome to the second half of 2022! +11,18% | 0,12 MDKK

2022-06-30 17:00:00 Cessatech reports Regulatory Green Light for trial 0205, the pivotal trial for CT001 - first patient expected shortly +1,40% | 0,02 MDKK

2022-05-16 08:15:00 Cessatech reports last patient dosed in pharmacokinetic trial in children of lead candidate +9,47% | 0,04 MDKK

2022-04-19 17:30:00 Cessatech: First quarter report Q1-2022 - preparing for the pivotal trial -3,11% | 0,03 MDKK

2022-03-31 09:00:00 Cessatech: Newsletter #6 - Mar 2022 +0,33% | 0,06 MDKK

2022-03-17 16:30:00 Minutes from the Annual General Meeting in Cessatech A/S +2,22% | 0,04 MDKK

2022-03-08 08:30:00 Cessatech reports successful outcome of bioavailability trial 0204 with CT001 -9,47% | 0,41 MDKK

2022-03-03 08:45:00 Cessatech A/S publishes annual report for the fiscal year 2021 +1,50% | 0,07 MDKK

2022-03-02 09:00:00 Cessatech A/S ("Cessatech" or the "Company") hereby convenes the annual general meeting to be held on 17 March 2022. -4,97% | 0,05 MDKK

2022-02-24 08:00:00 Cessatech: Fourth quarter report Q4-2021 - preparing for the pivotal trial -4,75% | 0,18 MDKK

2022-02-22 08:58:56 Cessatech expects to report on its bioavailability trial 0204 within a few weeks -1,54% | 0,06 MDKK

2022-01-06 08:00:00 Cessatech announces changes to the Board of Directors -0,11% | 0,02 MDKK

2022-01-04 17:00:00 Cessatech's warrant exercise registered with the Danish Companies Registration Office +4,40% | 0,07 MDKK

2021-12-30 16:00:00 Cessatech: Newsletter update #5 - Dec 2021 -7,79% | 0,23 MDKK

2021-12-22 13:07:59 Cessatech successfully raises approx. DKK 24.3 million through warrant exercise and does not activate guarantee commitments +6,52% | 0,43 MDKK

2021-12-14 08:00:00 Last day of trading in Cessatech's warrants of series TO 1 is today Tuesday 14 December 2021 -1,35% | 0,05 MDKK

2021-12-08 08:00:00 Cessatech: CEO and Board of Directors have exercised warrants of series TO 1 +7,49% | 0,12 MDKK

2021-11-25 08:07:18 Cessatech: The exercise period for warrants of series TO 1 begins today -2,47% | 0,04 MDKK

2021-11-19 08:00:00 Cessatech: Third quarter report Q3-2021 - focusing on next trial (0205) -3,79% | 0,08 MDKK

2021-11-12 17:30:00 Cessatech: Newsletter #4 - Nov 2021, Preparing for next year... +2,86% | 0,08 MDKK

2021-11-02 18:00:00 Cessatech annonces the issuance of its first US patent covering CT001 +1,05% | 0,91 MDKK

2021-08-20 08:00:00 Cessatech reports first patient dosed in pharmacokinetic trial in children of lead product candidate -2,51% | 0,32 MDKK

2021-08-19 08:00:00 Cessatech: Second quarter report Q2-2021 - planning for the pivotal trials -2,88% | 0,64 MDKK

2021-06-30 19:00:34 Cessatech: Newsletter: Preparing for the pivotal studies.... +0,61% | 0,10 MDKK

2021-06-29 08:07:40 Cessatech announces new Chairman of the Board - getting ready for the pivotal studies +4,47% | 0,13 MDKK

2021-05-31 07:45:00 Cessatech reports last subject dosed in bioavailability trial of lead product candidate -9,95% | 1,43 MDKK

2021-05-14 07:45:00 Cessatech A/S is awarded IPO of the year 2020 by independent editorial Affärsvärlden +8,70% | 0,73 MDKK

2021-04-19 08:00:00 Cessatech: First quarter report Q1-2021 - `one down, two to go' of the major milestones of 2021 +1,61% | 0,63 MDKK

2021-03-31 14:15:43 Cessatech: Newsletter #2 - Mar 2021 - Trial 0204 and 0206, and Company presentations +2,34% | 0,11 MDKK

2021-03-26 18:28:36 Minutes from the Annual General Meeting in Cessatech A/S -5,12% | 0,08 MDKK

2021-03-24 08:30:00 Cessatech reports first subject dosed in bioavailability trial of lead product candidate +0,36% | 0,19 MDKK

Visa fler

↑	Select newer press release
↓	Select older press release
←	Navigate backwards
→	Navigate forward
Enter	Navigate to line in focus
Tab	Focus next link
A or 1	Open First attachment
S or 2	Open Second attachment
D or 3	Open Third attachment
F or 4	Open Fourth attachment
I	Show company information
PgUp	Select newest press release
PgDown	Select oldest press release
L	Focus on filer bar
N	Increase preview window size
M	Decrease preview window size
Esc	Escape from mode

Cessatech

Kalender

Beskrivning

Språk

Typ

År

Språk

Typ

Ett mail har skickats till den givna adressen. För att logga in, klicka på "Login" i mailet för att verifiera ditt konto

Företag

Pressmeddelanden